Four-year clinical outcome of sirolimus- and paclitaxel-eluting stents compared to bare-metal stents for the percutaneous treatment of stable coronary artery disease-Reference-Cited by-同舟云学术

Four-year clinical outcome of sirolimus- and paclitaxel-eluting stents compared to bare-metal stents for the percutaneous treatment of stable coronary artery disease

Published:2010-03-01 Issue:1 Volume:76 Page:41-49
ISSN:1522-1946
Container-title:Catheterization and Cardiovascular Interventions
language:en
Short-container-title:Cathet. Cardiovasc. Intervent.

Author:

Simsek Cihan,Onuma Yoshinobu,Magro Michael,de Boer Sanneke,Battes Linda,van Domburg Ron T.,Boersma Eric,Serruys Patrick W.

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Radiology Nuclear Medicine and imaging,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ccd.22533/fullpdf

Reference34 articles.

1. for the COURAGE Trial Research Group. Optimal medical therapy with or without PCI for stable coronary disease;Boden;N Engl J Med,2007

2. on behalf of the COURAGE Trial Investigators. Optimal medical therapy with or without percutaneous coronary intervention in older patients with stable coronary disease;Teo;J Am Coll Cardiol,2009

3. Second Randomized Intervention Treatment of Angina (RITA-2) Trial Participants. Seven-year outcome in the RITA-2 trial: Coronary angioplasty versus medical therapy;Henderson;J Am Coll Cardiol,2003

4. A meta-analysis of 17 randomized trials of a percutaneous coronary intervention-based strategy in patients with stable coronary artery disease;Schomig;J Am Coll Cardiol,2008

5. Rita-2 Trial Participants. Coronary angioplasty versus medical therapy for angina: The second randomised intervention treatment of Angina (RITA-2) trial;Lancet,1997

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The contribution of matrix metalloproteinases and their inhibitors to the development, progression, and rupture of abdominal aortic aneurysms;Frontiers in Cardiovascular Medicine;2023-09-19

2. Ten-year clinical outcomes after sirolimus-eluting stent implantation: Impact of an in-stent restenosis target lesion;American Heart Journal;2016-05

3. Assessing Risk in Patients with Stable Coronary Disease: When Should We Intensify Care and Follow-Up? Results from a Meta-Analysis of Observational Studies of the COURAGE and FAME Era;Scientifica;2016

4. mTOR: A Novel Therapeutic Target for Diseases of Multiple Systems;Current Drug Targets;2015-09-30

5. Clinical Outcomes in Low Risk Coronary Artery Disease Patients Treated with Different Limus-Based Drug-Eluting Stents - A Nationwide Retrospective Cohort Study Using Insurance Claims Database;PLOS ONE;2015-04-07